Literature DB >> 33673334

Insulin-Like Growth Factor 2 As a Possible Neuroprotective Agent and Memory Enhancer-Its Comparative Expression, Processing and Signaling in Mammalian CNS.

Alexander Beletskiy1, Ekaterina Chesnokova1, Natalia Bal1.   

Abstract

A number of studies performed on rodents suggest that insulin-like growth factor 2 (IGF-2) or its analogs may possibly be used for treating some conditions like Alzheimer's disease, Huntington's disease, autistic spectrum disorders or aging-related cognitive impairment. Still, for translational research a comparative knowledge about the function of IGF-2 and related molecules in model organisms (rats and mice) and humans is necessary. There is a number of important differences in IGF-2 signaling between species. In the present review we emphasize species-specific patterns of IGF-2 expression in rodents, humans and some other mammals, using, among other sources, publicly available transcriptomic data. We provide a detailed description of Igf2 mRNA expression regulation and pre-pro-IGF-2 protein processing in different species. We also summarize the function of IGF-binding proteins. We describe three different receptors able to bind IGF-2 and discuss the role of IGF-2 signaling in learning and memory, as well as in neuroprotection. We hope that comprehensive understanding of similarities and differences in IGF-2 signaling between model organisms and humans will be useful for development of more effective medicines targeting IGF-2 receptors.

Entities:  

Keywords:  CNS; IGF-binding proteins; IGF1R; IGF2R/CI-M6P; insulin receptor; insulin-like growth factor 2; learning and memory; neuroprotection; species-specific gene expression

Mesh:

Substances:

Year:  2021        PMID: 33673334      PMCID: PMC7918606          DOI: 10.3390/ijms22041849

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  293 in total

1.  IGF-II binding to insulin receptor isoform A induces a partially different gene expression profile from insulin binding.

Authors:  Giuseppe Pandini; Enrico Conte; Enzo Medico; Laura Sciacca; Riccardo Vigneri; Antonino Belfiore
Journal:  Ann N Y Acad Sci       Date:  2004-12       Impact factor: 5.691

2.  Quantitative analysis of the olfactory pathway for drug delivery to the brain.

Authors:  R G Thorne; C R Emory; T A Ala; W H Frey
Journal:  Brain Res       Date:  1995-09-18       Impact factor: 3.252

3.  RSRC1 mutation affects intellect and behaviour through aberrant splicing and transcription, downregulating IGFBP3.

Authors:  Yonatan Perez; Shay Menascu; Idan Cohen; Rotem Kadir; Omer Basha; Zamir Shorer; Hila Romi; Gal Meiri; Tatiana Rabinski; Rivka Ofir; Esti Yeger-Lotem; Ohad S Birk
Journal:  Brain       Date:  2018-04-01       Impact factor: 13.501

4.  Insulin-like growth factor-II (IGF-II) and IGF-II analogs with enhanced insulin receptor-a binding affinity promote neural stem cell expansion.

Authors:  Amber N Ziegler; Shravanthi Chidambaram; Briony E Forbes; Teresa L Wood; Steven W Levison
Journal:  J Biol Chem       Date:  2014-01-07       Impact factor: 5.157

5.  Distinctive regulation of the functional linkage between the human cation-independent mannose 6-phosphate receptor and GTP-binding proteins by insulin-like growth factor II and mannose 6-phosphate.

Authors:  Y Murayama; T Okamoto; E Ogata; T Asano; T Iiri; T Katada; M Ui; J H Grubb; W S Sly; I Nishimoto
Journal:  J Biol Chem       Date:  1990-10-15       Impact factor: 5.157

6.  Insulin-like growth factor II expression in the developing human brain.

Authors:  P A McKelvie; K M Rosen; H C Kinney; L Villa-Komaroff
Journal:  J Neuropathol Exp Neurol       Date:  1992-07       Impact factor: 3.685

Review 7.  Structure and function of the type 1 insulin-like growth factor receptor.

Authors:  T E Adams; V C Epa; T P Garrett; C W Ward
Journal:  Cell Mol Life Sci       Date:  2000-07       Impact factor: 9.261

8.  Normal growth and development in the absence of hepatic insulin-like growth factor I.

Authors:  S Yakar; J L Liu; B Stannard; A Butler; D Accili; B Sauer; D LeRoith
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

9.  Differential gene expression of insulin receptor isoforms A and B and insulin receptor substrates 1, 2 and 3 in rat tissues: modulation by aging and differentiation in rat adipose tissue.

Authors:  R Serrano; M Villar; C Martínez; J M Carrascosa; N Gallardo; A Andrés
Journal:  J Mol Endocrinol       Date:  2005-02       Impact factor: 5.098

10.  Comparative transcriptomics of choroid plexus in Alzheimer's disease, frontotemporal dementia and Huntington's disease: implications for CSF homeostasis.

Authors:  Edward G Stopa; Keith Q Tanis; Miles C Miller; Elena V Nikonova; Alexei A Podtelezhnikov; Eva M Finney; David J Stone; Luiz M Camargo; Lisan Parker; Ajay Verma; Andrew Baird; John E Donahue; Tara Torabi; Brian P Eliceiri; Gerald D Silverberg; Conrad E Johanson
Journal:  Fluids Barriers CNS       Date:  2018-05-31
View more
  2 in total

1.  Time-restricted feeding entrains long-term behavioral changes through the IGF2-KCC2 pathway.

Authors:  Qiaocheng Zhai; Yizhun Zeng; Yue Gu; Zhihao Li; Tao Zhang; Baoshi Yuan; Tao Wang; Jie Yan; Han Qin; Ling Yang; Xiaowei Chen; Antonio Vidal-Puig; Ying Xu
Journal:  iScience       Date:  2022-04-18

2.  Insulin-like Growth Factor II Prevents MPP+ and Glucocorticoid Mitochondrial-Oxidative and Neuronal Damage in Dopaminergic Neurons.

Authors:  Silvia Claros; Pablo Cabrera; Nadia Valverde; Silvana Y Romero-Zerbo; Manuel Víctor López-González; Kirill Shumilov; Alicia Rivera; Jose Pavia; Elisa Martín-Montañez; María Garcia-Fernandez
Journal:  Antioxidants (Basel)       Date:  2021-12-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.